Article info
PDFColon
Original article
Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study
- Correspondence to Gwen Murphy, Metabolic Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, 9609 Medical Center Dr, 6E428, Bethesda, MD 20850, USA; murphygw{at}mail.nih.gov
Citation
Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study
Publication history
- Received October 5, 2016
- Revised June 27, 2017
- Accepted June 28, 2017
- First published August 16, 2017.
Online issue publication
November 24, 2018
Article Versions
- Previous version (24 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.